Shareholder Class Action

Shareholders claim Vertex Pharmaceuticals inflated its share price by failing to disclose adverse information about its experimental hepatitis C drug, VX-950 (telaprevir), in Boston Federal Court.

Shareholders accuse directors of Candela Corp. or wasting corporate assets and breaching fiduciary duties, in Middlesex County Court, Woburn, Mass.

Shareholders accuse Familymedsgroup of wasting more than $80 million in corporate assets, in Hartford Superior Court.

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Email *

Submit